A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Eli Lilly and Company
IGM Biosciences, Inc.
Emory University
University of Miami
Grupo Espanol de Investigacion en Sarcomas
University of Iowa
University of Iowa
Masonic Cancer Center, University of Minnesota
Altor BioScience
M.D. Anderson Cancer Center
New Mexico Cancer Research Alliance
Dartmouth-Hitchcock Medical Center